Vividion Therapeutics, Inc.
Clinical trials sponsored by Vividion Therapeutics, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill targets Hard-to-Treat cancers in early trial Results expected May 2027 (estimated)
- New cancer drug combo enters first human tests Results expected Aug 2027 (estimated)